cediranib clinical trials

Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

This study looks at how your body handles a new cancer drug called cediranib when you also take a common medicine called rifampicin. It helps researchers understand how these drugs work together in patients with advanced solid tumours, aiming for safer and more effective treatments.